JPRN-UMIN000019253Active, not recruiting未知
Examination of the effect by taking the sodium glucose transporter 2 inhibitor everyday or only when a patient thinks it to be necessary for type 2 diabetes patients controlled inadequately.
Toho University School of Medicine, Division of diabetes, metabolism and endocrinology0 sites50 target enrollmentStarted: October 6, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- •(1)Type 2 diabetes patients controlled inadequately with 7.0 to 9.9%.
- •(2)Patient taking equal or less than three kinds of oral anti-diabete drugs in addition to diet and exercise therapy for 12 weeks or more.
- •(3)Patients who does not use human GLP-1 analog or insulin.
- •(4)Adalts who are 20 years or older and 75 years or younger.
- •(5)Patients who can understand consent brief and other explanation documents having the ability of the agreement about participation in examination.
Exclusion Criteria
- •(1) Type 1 diabetes mellitus patients or secondary diabetic mellitus.
- •(2) Patients who had myocardial infarction within 3 months, or obvious heart failure case.
- •(3) Patients who had the past hypersensitivity for the used drug.
- •(4) Patients with diabetic ketoacidosis or diabetic coma or risk of diabetic coma.
- •(5) Patients with severe liver disease.
- •(6) Patients with severe renal disease.
- •(7) Patients with severe pancreas disease.
- •(8) Patients with hemoglobin (Hb) less than 11 g/dL.
- •(9) Patient during cancer treatment
- •(10) Patients that the number of the platelets is less than 100,000 /mm3.
- •(11) Patients with severe diabetic neuropathy.
- •(12) Patients having a proliferative retinopathy.
- •(13) Patients with a serious infectious disease or a serious injury.
- •(14) Excessive common custom drinker
- •(15) A pregnant woman or the woman who may be pregnant.
- •(16) In addition, the patients who will be judged inappropriate by an attendant physician.
Investigators
Similar Trials
Completed
Not Applicable
Investigation of the effect of the Egualen Sodium Hydrate mouthwash on the stomatitis induced by the gastroenterological cancer chemotherapystomatitisJPRN-UMIN000005599Department of Gastroenterology, Tokushima University Hospital10
Recruiting
Not Applicable
The beneficial effects of newer antidiabetic drugs(Sodium Glucose Co-Transporters type 2) inhibitors for the treatment of raised blood glucose levelCTRI/2019/03/018307Jawaharlal Nehru Medical College and Hospital
Recruiting
Phase 3
Does sodium valproate reduce delirium after head injury?CTRI/2017/03/008058Christian Medical College Vellore128
Recruiting
Not Applicable
Investigation on the effect of sodium intake and anti-hypertensive therapy in the treatment HypertensioHypertensionJPRN-UMIN000005916Department of Cardiovascular Medicine100
Recruiting
Not Applicable
The clinical study to explore the effects of sodium-dependent glucose co-transporter 2 inhibitors on responses of orexigenic hormone 'ghrelin' in patients with type 2 diabetestype 2 diabetes mellitusJPRN-UMIN000014223Wakayama medical university, the first department of medicine60